| Site | Protocol | Description
| Breast
| N0733
| Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 in Patients with HER2 Positive Breast Cancer Previously Treated with Trastuzumab and an Anthracycline and/or a Taxane
| Breast
| N0937
| Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer
| Breast
| N093B
| Phase I/II study of Panobinostat (LBH589) and letrozole in patients with triple negative metastatic breast cancer
| CNS
| N0572
| A Phase I/II Trial of Sorafenib and CCI-779 in Patients with Recurrent Glioblastoma
| CNS
| N0574
| A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Metastases
| CNS
| N0577
| Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma
| CNS
| N057K
| Phase I/II Evaluation of Everolimus (RAD001), Radiation and Temozolomide (TMZ) Followed by Adjuvant Temozolomide and Everolimus in Newly Diagnosed Glioblastoma
| CNS
| N0872
| Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma
| CNS
| N0874
| Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]), Temozolomide, and Radiation Therapy in Patients with Newly Diagnosed Glioblastoma
| CNS
| N0877
| Phase I/Randomized Phase II Trial of Either Dasatinib or Placebo Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme (GBM)
| CNS
| N107C
| A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
| GI
| N0949
| Randomized Phase III Trial of mFOLFOX7 or XELOX Plus Bevacizumab Versus 5-Fluorouracil/Leucovorin or Capecitabine Plus Bevacizumab as First-line Treatment in Elderly Patients with Metastatic Colorectal Cancer
| GI
| N0849
| Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Gastric Cardia
| GI
| N1048
| A Phase II/III Trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision
| GI
| N0543
| A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma
| GI
| N0849
| Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Gastric Cardia
| Hematology
| N1087
| Phase I/II Study of the Combination of Bendamustine, Rituximab and MK-2206 in the Treatment of Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
| Hematology
| N078D
| Phase I/II Trial of Rituximab, Cladribine, and Temsirolimus (RCT) Therapy in Newly Diagnosed Mantle Cell Lymphoma (MCL)
| Hematology
| N078D
| Phase I/II Trial of Rituximab, Cladribine, and Temsirolimus (RCT) Therapy in Newly Diagnosed Mantle Cell Lymphoma (MCL)
| Lung
| N0923
| A Randomized Double-Blinded Phase II Study of NTX-010, a Replication-Competent Picornavirus, After Standard Platinum-Containing Cytroreductive Induction Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer
| Melanoma
| N0879
| A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, with or without Everolimus for Therapy of Metastatic Malignant Melanoma
| Unknown
| N0871
| A Phase II Study of Carboplatin (CBDCA), Paclitaxel (TAXOL), and Everolimus (RAD001) in Previously Untreated Patients with Measurable Disease with Cancer of Unknown Primary (CUP)
| |
|---|
| Site | Protocol | Description | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast | N10C1 | Vaginal DHEA for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study
| Breast
| N10C2
| Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes
| GI
| N08C9
| Phase III, Randomized Study of Sulfasalazine versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
| GI
| N08CB
| A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity
| GYN
| N10C1
| Vaginal DHEA for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study
| Head & Neck
| N09C6
| Randomized Double-Blind Study of Doxepin Rinse versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy with or without Chemotherapy
| Multiple
| N08C1
| Paclitaxel-Associated Acute Pain Syndrome Natural History Study
| Other
| N07C4
| A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances
| Other
| N08C1
| Paclitaxel-Associated Acute Pain Syndrome Natural History Study
| Other
| N08C9
| Phase III, Randomized Study of Sulfasalazine versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy
| Other
| N08CB
| A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity
| Other
| N09C6
| Randomized Double-Blind Study of Doxepin Rinse versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy with or without Chemotherapy
| Other
| N10C1
| Vaginal DHEA for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study
| |
| Site | Protocol | Description | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast | N0832 | Round-Robin Clinico-pathological Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (N9831, BCIRG 006, and BCIRG 005)
| Breast
| N0832
| Round-Robin Clinico-pathological Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (N9831, BCIRG 006, and BCIRG 005)
| CNS
| 947252
| Diagnostic and Prognostic Markers in High-Grade Glioma
| CNS
| 947253
| Diagnostic and Prognostic Markers in Low-Grade Gliomas
| CNS
| N0477
| Optimizing EGFR Inhibitor-Based Therapies for GBM
| Multiple
| N0392
| Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG Clinical Trials
| |